Trial ID or NCT#



not recruiting iconNOT RECRUITING


This trial is a 12-week, randomized, double-blind, placebo controlled, multicenter, 4-treatment parallel group study of the safety and efficacy of JZP-110 in the treatment of excessive sleepiness in adult subjects with narcolepsy.

Official Title

A Twelve-week, Double-blind, Placebo-controlled, Randomized, Parallel-group, Multicenter Study of the Safety and Efficacy of JZP-110 [(R)-2-amino-3-phenylpropylcarbamate Hydrochloride] in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy

Eligibility Criteria

Ages Eligible for Study: 18 Years to 75 Years
Sexes Eligible for Study: All
Accepts Healthy Volunteers: No


Emmanuel Mignot, MD, PhD
Emmanuel Mignot, MD, PhD
Sleep specialist
Craig Reynolds Professor of Sleep Medicine and Professor, by courtesy, of Genetics and of Neurology

Contact us to find out if this trial is right for you.


Saba Mizra
(650) 721-5489